India’s Central Government, following the 56th GST Council meeting held on September 3, 2025, has announced a major overhaul of the country’s indirect tax system. In a bid to simplify taxation and improve transparency, the government is transitioning to a streamlined two-tier GST structure.
Under the revised system, goods and services across the country will now fall under either the 5% or 18% GST bracket, replacing the earlier four-slab structure of 5%, 12%, 18%, and 28%. This shift aims to make compliance easier and pricing more consistent. Additionally, in a significant move aimed at enhancing access to critical healthcare, the government has completely exempted a number of life-saving medicines from GST.
---Advertisement---
Life-Saving Medicines to Get Cheaper from Monday
Starting Monday, September 22, 2025, 36 essential life-saving medicines and drugs will become more affordable, as the government has decided to waive the existing 5% GST on most of them. This move is expected to make critical treatments more accessible to the public and encourage wider availability of essential drugs across the nation.
---Advertisement---
Here’s a paraphrased list of all the medicines mentioned in your passage, grouped by their GST changes:
Medicines Now at Zero GST (Previously 12%):
- Agalsidase Beta
- Imiglucerase
- Eptacog alfa activated recombinant coagulation factor VIIa
- Onasemnogene abeparvovec
- Asciminib
- Mepolizumab
- Pegylated Liposomal Irinotecan
- Daratumumab
- Daratumumab subcutaneous
- Teclistamab
- Amivantamab
- Alectinib
- Risdiplam
- Obinutuzumab
- Polatuzumab vedotin
- Entrectinib
- Atezolizumab
- Spesolimab
- Velaglucerase Alpha
- Agalsidase Alfa
- Rurioctocog Alpha Pegol
- Idursulphatase
- Alglucosidase Alfa
- Laronidase
- Olipudase Alfa
- Tepotinib
- Avelumab
- Emicizumab
- Belumosudil
- Miglustat
- Velmanase Alfa
- Alirocumab
- Evolocumab
- Cystamine Bitartrate
- CI-Inhibitor injection
- Inclisiran
Medicines Now at Reduced GST of 5% (Previously 12%):
- All drugs and medicines containing:
- Fluticasone Furoate + Umeclidinium + Vilanterol (FF/UMEC/VI)
- Brentuximab Vedotin
- Ocrelizumab
- Pertuzumab
- Pertuzumab + Trastuzumab
- Faricimab
Here’s a paraphrased list of all the medicines mentioned in your passage, grouped by their GST changes:
Medicines Now at Zero GST (Previously 12%):
- Agalsidase Beta
- Imiglucerase
- Eptacog alfa activated recombinant coagulation factor VIIa
- Onasemnogene abeparvovec
- Asciminib
- Mepolizumab
- Pegylated Liposomal Irinotecan
- Daratumumab
- Daratumumab subcutaneous
- Teclistamab
- Amivantamab
- Alectinib
- Risdiplam
- Obinutuzumab
- Polatuzumab vedotin
- Entrectinib
- Atezolizumab
- Spesolimab
- Velaglucerase Alpha
- Agalsidase Alfa
- Rurioctocog Alpha Pegol
- Idursulphatase
- Alglucosidase Alfa
- Laronidase
- Olipudase Alfa
- Tepotinib
- Avelumab
- Emicizumab
- Belumosudil
- Miglustat
- Velmanase Alfa
- Alirocumab
- Evolocumab
- Cystamine Bitartrate
- CI-Inhibitor injection
- Inclisiran
Medicines Now at Reduced GST of 5% (Previously 12%):
- All drugs and medicines containing:
- Fluticasone Furoate + Umeclidinium + Vilanterol (FF/UMEC/VI)
- Brentuximab Vedotin
- Ocrelizumab
- Pertuzumab
- Pertuzumab + Trastuzumab
- Faricimab